Emerging trends in the novel drug delivery approaches for the treatment of lung cancer

Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.

Full text not available from this repository.
Item Type: Article
Status: Published
Official URL: https://doi.org/10.1016/j.cbi.2019.06.033
Journal or Publication Title: Chemico-Biological Interactions
Volume: 309
Page Range: p. 108720
Date: 2019
Divisions: UTS Centre for Inflammation
Depositing User: General Admin
Identification Number: 10.1016/j.cbi.2019.06.033
ISSN: 00092797
Date Deposited: 21 Dec 2020 23:12

Cancer is one of the major diseases that cause a high number of deaths globally. Of the major types of cancers, lung cancer is known to be the most chronic form of cancer in the world. The conventional management of lung cancer includes different medical interventions like chemotherapy, surgical removal, and radiation therapy. However, this type of approach lacks specificity and also harms the adjacent normal cells. Lately, nanotechnology has emerged as a promising intervention in the management and treatment of lung cancers. Nanotechnology has revolutionized the existing modalities and focuses primarily on reducing toxicity and improving the bioavailability of anticancer drugs to the target tumor cells. Nanocarrier systems are being currently used extensively to exploit and to overcome the obstructions induced by cancers in the lungs. The nano-carrier-loaded therapeutic drug delivery methods have shown promising potential in treating lung cancer as its target is to control the growth of tumor cells. In this review, various modes of nano drug delivery options like liposomes, dendrimers, quantum dots, carbon nanotubes and metallic nanoparticles have been discussed. Nano-carrier drug delivery systems emerge as a promising approach and thus is expected to provide newer and advanced avenues in cancer therapeutics.

Keywords: Cancer; Lung cancer; Nano-carrier; Nanotechnology; Target drug delivery.

Copyright © 2019 Elsevier B.V. All rights reserved.

Sharma, Parvarish
Mehta, Meenu
Dhanjal, Daljeet Singh
Kaur, Simran
Gupta, Gaurav
Singh, Harjeet
Thangavelu, Lakshmi
Rajeshkumar, S.
Tambuwala, Murtaza
Bakshi, Hamid A.
Chellappan, Dinesh Kumar
Dua, Kamal
Satija, Saurabh
Last Modified: 21 Dec 2020 23:12
URI: https://eprints.centenary.org.au/id/eprint/152

Actions (login required)

View Item View Item